Related Experiment Video
Updated: Mar 6, 2026

Quantification of Immunostained Caspase-9 in Retinal Tissue
Published on: July 25, 2022
[Peptide drug cortexin inhibits brain caspase-8]
A A Yakovlev1, A A Lyzhin2, L G Khaspekov2
1Institute of Higher Nervous Activity and Neurophysiology, Moscow, Russia; Moscow Research and Clinical Center for Neuropsychiatry, Moscow, Russia.
Abstract:
Cortexin, a drug containing hydrolyzed brain peptides, has long been used in clinics, but the mechanisms of its action remain obscure. We have hypothesized that cortexin-related neuroprotection is associated with the ability of the drug to inhibit brain proteases. Cortexin effectively inhibited brain caspase-8, while its effects on caspase-1, -3, -9, cathepsin B and calpain were much less pronounced or absent. In addition, we isolated a peptide fraction from cortexin holding all the inhibitory capacity of the original drug, but with a much more simple composition. Both cortexin and its fraction prevented neuronal damage in a culture model of glutamate-induced cell death. Neuroprotective effect of Cortexin may be mediated by inhibition of the initiator caspase-8 in the brain.
Related Concept Videos
Caspases
The Extrinsic Apoptotic Pathway

